MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations
Iléana Antony‐Debré(Inserm), Hana Raslová(Inserm)
Cited by 79
Related Papers
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
|Blood|2014|96
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
|Cancer Discovery|2020|26
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
|Blood|2019|5